Aflac Incorporated (NYSE:AFL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(c)As reflected in the definitive proxy statement on Schedule 14A (the “Proxy Statement”) for the 2018 Annual Meeting of Shareholders of Aflac Incorporated (the “Company”), which was filed with the U.S. Securities and Exchange Commission on March 23, 2018, Daniel P. Amos was appointed President of the Company on February 13, 2018. Mr. Amos also currently serves as the Company’s Chairman and Chief Executive Officer. Information regarding Mr. Amos’ background, business experience and compensation is incorporated by reference herein from the Proxy Statement.

About Aflac Incorporated (NYSE:AFL)

Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells supplemental insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans and loss-of-income products.